+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

From
From
From
From
From
Pustular Psoriasis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Pustular Psoriasis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • September 2025
  • 94 Pages
  • Global
From
Dermatophytosis: Market View - Product Thumbnail Image

Dermatophytosis: Market View

  • Report
  • September 2025
  • 85 Pages
  • Global
From
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • August 2025
  • 1403 Pages
  • Global
From
From
From
From
From
Erythrodermic Psoriasis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Erythrodermic Psoriasis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 52 Pages
  • Global
From
Actinic (Solar) Keratosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Actinic (Solar) Keratosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 289 Pages
  • Global
From
Seborrheic Keratosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Seborrheic Keratosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • January 2025
  • 47 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more